{"pmid":32314871,"title":"Targeting the Adipose Tissue in COVID-19.","text":["Targeting the Adipose Tissue in COVID-19.","The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients.","Obesity (Silver Spring)","Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca","32314871"],"abstract":["The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients."],"journal":"Obesity (Silver Spring)","authors":["Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314871","week":"202017|Apr 20 - Apr 26","doi":"10.1002/oby.22844","keywords":["ace2","covid-19","adipose tissue: dpp4"],"source":"PubMed","topics":["Treatment"],"weight":1,"locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"_version_":1664714520065474561,"score":8.518259,"similar":[{"pmid":32314868,"title":"Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation and Cytokine Amplification in COVID-19.","text":["Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation and Cytokine Amplification in COVID-19.","Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcome include advanced age, male gender, pre-existing cardiovascular disease and risk factors including hypertension, diabetes and more recently obesity. Herein, we posit new obesity-driven predictors of poor COVID-19 outcome, over and above the more obvious extant risks associated with obesity including cardiometabolic disease and hypoventilation syndrome in intensive care patients. We outline a theoretical mechanistic framework whereby adipose tissue in subjects with obesity may act as a reservoir for more extensive viral spread with increased shedding, immune activation and cytokine amplification. We propose studies to test this reservoir concept with a focus on specific cytokine pathways that might be amplified in subjects with obesity and COVID-19. Finally, we underscore emerging therapeutic strategies that might benefit subsets of patients in which cytokine amplification is excessive and potentially fatal.","Obesity (Silver Spring)","Ryan, Paul MacDaragh","Caplice, Noel M","32314868"],"abstract":["Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcome include advanced age, male gender, pre-existing cardiovascular disease and risk factors including hypertension, diabetes and more recently obesity. Herein, we posit new obesity-driven predictors of poor COVID-19 outcome, over and above the more obvious extant risks associated with obesity including cardiometabolic disease and hypoventilation syndrome in intensive care patients. We outline a theoretical mechanistic framework whereby adipose tissue in subjects with obesity may act as a reservoir for more extensive viral spread with increased shedding, immune activation and cytokine amplification. We propose studies to test this reservoir concept with a focus on specific cytokine pathways that might be amplified in subjects with obesity and COVID-19. Finally, we underscore emerging therapeutic strategies that might benefit subsets of patients in which cytokine amplification is excessive and potentially fatal."],"journal":"Obesity (Silver Spring)","authors":["Ryan, Paul MacDaragh","Caplice, Noel M"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314868","week":"202017|Apr 20 - Apr 26","doi":"10.1002/oby.22843","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664714520160894977,"score":342.13342},{"pmid":32249357,"title":"Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.","text":["Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.","AIMS: Analyze the relationship between obesity and influenza. METHODS: Basal hormone milieu, defective response of both innate and adaptive immune system and sedentariness are major determinants in the severity of influenza viral infection in obese patients. Being overweight not only increases the risk of infection and of complications for the single obese person, but a large prevalence of obese individuals within the population might increase the chance of appearance of more virulent viral strain, prolongs the virus shedding throughout the total population and eventually might increase overall mortality rate of an influenza pandemic. RESULTS: Waiting for the development of a vaccination against COVID-19, isolation of positive cases and social distancing are the primary interventions. Nonetheless, evidence from previous influenza pandemics suggests the following interventions aimed at improving immune response: (1) lose weight with a mild caloric restriction; (2) include AMPK activators and PPAR gamma activators in the drug treatment for obesity associated with diabetes; and (3) practice mild-to-moderate physical exercise. CONCLUSIONS: Due to prolonged viral shedding, quarantine in obese subjects should likely be longer than normal weight individuals.","Acta Diabetol","Luzi, Livio","Radaelli, Maria Grazia","32249357"],"abstract":["AIMS: Analyze the relationship between obesity and influenza. METHODS: Basal hormone milieu, defective response of both innate and adaptive immune system and sedentariness are major determinants in the severity of influenza viral infection in obese patients. Being overweight not only increases the risk of infection and of complications for the single obese person, but a large prevalence of obese individuals within the population might increase the chance of appearance of more virulent viral strain, prolongs the virus shedding throughout the total population and eventually might increase overall mortality rate of an influenza pandemic. RESULTS: Waiting for the development of a vaccination against COVID-19, isolation of positive cases and social distancing are the primary interventions. Nonetheless, evidence from previous influenza pandemics suggests the following interventions aimed at improving immune response: (1) lose weight with a mild caloric restriction; (2) include AMPK activators and PPAR gamma activators in the drug treatment for obesity associated with diabetes; and (3) practice mild-to-moderate physical exercise. CONCLUSIONS: Due to prolonged viral shedding, quarantine in obese subjects should likely be longer than normal weight individuals."],"journal":"Acta Diabetol","authors":["Luzi, Livio","Radaelli, Maria Grazia"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249357","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s00592-020-01522-8","keywords":["COVID-19","Immune-modulation","Influenza","Obese subjects"],"source":"PubMed","locations":["obese"],"topics":["Treatment"],"weight":1,"_version_":1663352136309669889,"score":312.49918},{"pmid":32271993,"title":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","text":["High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","OBJECTIVE: The Covid-19 pandemic is rapidly spreading worldwide, notably in Europe and North America, where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has not been fully documented. METHODS: In this retrospective cohort study we analyzed the relationship between clinical characteristics, including body mass index (BMI), and the requirement for invasive mechanical ventilation (IMV) in 124 consecutive patients admitted in intensive care for SARS-CoV-2, in a single French center. RESULTS: Obesity (BMI >30 kg/m2) and severe obesity (BMI >35 kg/m2) were present in 47.6% and 28.2% of cases, respectively. Overall, 85 patients (68.6%) required IMV. The proportion of patients who required IMV increased with BMI categories (p<0.01, Chi square test for trend), and it was greatest in patients with BMI >35 kg/m2 (85.7%). In multivariate logistic regression, the need for IMV was significantly associated with male sex (p<0.05) and BMI (p<0.05), independent of age, diabetes, and hypertension. The odds ratio for IMV in patients with BMI >35 kg/m2 vs patients with BMI <25 kg/m2 was 7.36 (1.63-33.14; p=0.02) CONCLUSION: The present study showed a high frequency of obesity among patients admitted in intensive care for SARS-CoV-2. Disease severity increased with BMI. Obesity is a risk factor for SARS-CoV-2 severity requiring increased attention to preventive measures in susceptible individuals.","Obesity (Silver Spring)","Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce","32271993"],"abstract":["OBJECTIVE: The Covid-19 pandemic is rapidly spreading worldwide, notably in Europe and North America, where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has not been fully documented. METHODS: In this retrospective cohort study we analyzed the relationship between clinical characteristics, including body mass index (BMI), and the requirement for invasive mechanical ventilation (IMV) in 124 consecutive patients admitted in intensive care for SARS-CoV-2, in a single French center. RESULTS: Obesity (BMI >30 kg/m2) and severe obesity (BMI >35 kg/m2) were present in 47.6% and 28.2% of cases, respectively. Overall, 85 patients (68.6%) required IMV. The proportion of patients who required IMV increased with BMI categories (p<0.01, Chi square test for trend), and it was greatest in patients with BMI >35 kg/m2 (85.7%). In multivariate logistic regression, the need for IMV was significantly associated with male sex (p<0.05) and BMI (p<0.05), independent of age, diabetes, and hypertension. The odds ratio for IMV in patients with BMI >35 kg/m2 vs patients with BMI <25 kg/m2 was 7.36 (1.63-33.14; p=0.02) CONCLUSION: The present study showed a high frequency of obesity among patients admitted in intensive care for SARS-CoV-2. Disease severity increased with BMI. Obesity is a risk factor for SARS-CoV-2 severity requiring increased attention to preventive measures in susceptible individuals."],"journal":"Obesity (Silver Spring)","authors":["Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271993","week":"202015|Apr 06 - Apr 12","doi":"10.1002/oby.22831","keywords":["covid-19","sras-cov-2","body mass index","intensive care","mechanical ventilation","obesity"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"locations":["French"],"countries":["France"],"countries_codes":["FRA|France"],"_version_":1664637315703635970,"score":236.14084},{"pmid":32324968,"title":"Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?","text":["Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in China in late 2019 and has since spread rapidly to every continent in the world. This pandemic continues to cause widespread personal suffering, along with severe pressure on medical and health care providers. The symtoms of SARS-CoV-2 and the subsequent prognosis is worsened in individuals who have pre-exisiting comorbidities prior to infection by the virus. Individuals with obesity/overweight, insulin resistance and diabetes typically have chronic low-grade inflammation characterized by increased levels of several pro-inflammatory cytokines and the inflammasome: this state predisposes to greater risk for infection along with more adverse outcomes. Here we consider whether a high level of cardiorespiratory fitness induced by prior exercise training may confer some innate immune-protection against Covid-19 by attenuating the \"cytokine storm syndrome\" often experienced by \"at risk\" individuals.","Obesity (Silver Spring)","Zbinden-Foncea, Hermann","Francaux, Marc","Deldicque, Louise","Hawley, John A","32324968"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in China in late 2019 and has since spread rapidly to every continent in the world. This pandemic continues to cause widespread personal suffering, along with severe pressure on medical and health care providers. The symtoms of SARS-CoV-2 and the subsequent prognosis is worsened in individuals who have pre-exisiting comorbidities prior to infection by the virus. Individuals with obesity/overweight, insulin resistance and diabetes typically have chronic low-grade inflammation characterized by increased levels of several pro-inflammatory cytokines and the inflammasome: this state predisposes to greater risk for infection along with more adverse outcomes. Here we consider whether a high level of cardiorespiratory fitness induced by prior exercise training may confer some innate immune-protection against Covid-19 by attenuating the \"cytokine storm syndrome\" often experienced by \"at risk\" individuals."],"journal":"Obesity (Silver Spring)","authors":["Zbinden-Foncea, Hermann","Francaux, Marc","Deldicque, Louise","Hawley, John A"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324968","week":"202017|Apr 20 - Apr 26","doi":"10.1002/oby.22849","keywords":["covid-19","obesity","exercise","immune system","insulin resistance"],"source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664895932757442560,"score":232.4085},{"pmid":32320741,"title":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.","text":["Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.","BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) has been declared a pandemic in 2020. Patients with metabolic associated fatty liver disease (MAFLD) are often obese and have additional metabolic risk factors which may aggravate the severity of respiratory diseases and of COVID-19. This study aims to investigate the association between MAFLD and COVID-19 severity. METHODS: 214 patients with laboratory-confirmed COVID-19 aged between 18 and 75years from three hospitals in Wenzhou, China were consecutively enrolled. Sixty-six patients with MAFLD were included in the final analysis. COVID-19 was diagnosed as a positive result by high-throughput sequencing or real-time reverse transcriptase-polymerase chain reaction assay of oropharyngeal swab specimens. COVID-19 severity was assessed during hospitalization and classified as severe and non-severe based on the current management guideline. All patients were screened for fatty liver by computed tomography and subsequently diagnosed as MAFLD according to a recent set of consensus diagnostic criteria. Obesity was defined as BMI >25kg/m(2). RESULTS: The presence of obesity in MAFLD patients was associated with a~6-fold increased risk of severe COVID-19 illness (unadjusted-OR 5.77, 95% CI 1.19-27.91, p=.029). Notably, this association with obesity and COVID-19 severity remained significant (adjusted-OR 6.32, 95% CI 1.16-34.54, p=.033) even after adjusting for age, sex, smoking, diabetes, hypertension, and dyslipidaemia. CONCLUSIONS: Our data demonstrate that the risk of obesity to COVID-19 severity is greater in those with, than those without MAFLD.","Metabolism","Zheng, Kenneth I","Gao, Feng","Wang, Xiao-Bo","Sun, Qing-Feng","Pan, Ke-Hua","Wang, Ting-Yao","Ma, Hong-Lei","Liu, Wen-Yue","George, Jacob","Zheng, Ming-Hua","32320741"],"abstract":["BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) has been declared a pandemic in 2020. Patients with metabolic associated fatty liver disease (MAFLD) are often obese and have additional metabolic risk factors which may aggravate the severity of respiratory diseases and of COVID-19. This study aims to investigate the association between MAFLD and COVID-19 severity. METHODS: 214 patients with laboratory-confirmed COVID-19 aged between 18 and 75years from three hospitals in Wenzhou, China were consecutively enrolled. Sixty-six patients with MAFLD were included in the final analysis. COVID-19 was diagnosed as a positive result by high-throughput sequencing or real-time reverse transcriptase-polymerase chain reaction assay of oropharyngeal swab specimens. COVID-19 severity was assessed during hospitalization and classified as severe and non-severe based on the current management guideline. All patients were screened for fatty liver by computed tomography and subsequently diagnosed as MAFLD according to a recent set of consensus diagnostic criteria. Obesity was defined as BMI >25kg/m(2). RESULTS: The presence of obesity in MAFLD patients was associated with a~6-fold increased risk of severe COVID-19 illness (unadjusted-OR 5.77, 95% CI 1.19-27.91, p=.029). Notably, this association with obesity and COVID-19 severity remained significant (adjusted-OR 6.32, 95% CI 1.16-34.54, p=.033) even after adjusting for age, sex, smoking, diabetes, hypertension, and dyslipidaemia. CONCLUSIONS: Our data demonstrate that the risk of obesity to COVID-19 severity is greater in those with, than those without MAFLD."],"journal":"Metabolism","authors":["Zheng, Kenneth I","Gao, Feng","Wang, Xiao-Bo","Sun, Qing-Feng","Pan, Ke-Hua","Wang, Ting-Yao","Ma, Hong-Lei","Liu, Wen-Yue","George, Jacob","Zheng, Ming-Hua"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320741","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.metabol.2020.154244","keywords":["covid-19","mafld","obesity","sars-cov-2"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["obese","Wenzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664815087808937986,"score":230.8686}]}